<!DOCTYPE html>
<html>
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" type="text/css" href="css/style-manual.css">
    <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
    <script src="js/script.js"></script>
</head>
<body>
<!--Nafgal-------------------------------------------------------->
<div class="bodyDiv" id="idNafgal">
    <div class="w3-container w3-center w3-animate-left">
        <h2 class="mango">Nafgal</h2>
    </div>
<b>Product Orientation & Presentation:</b><br>
<table class="table1">
 <tr>
    <th>Brand Name:</th>
    <th>Arokast.</th>
  </tr>

  <tr>
 
    <td>Generic & Strength:</td>
	<td>Montelukast USP 10 mg (Film Coated).<br>
   4 mg & 5 mg Chewable.<br>
4 mg & 5 mg Flash Tablet.</td>
    
  </tr>
  
  <tr>
    <td>Dosage Form:</td>
    <td>Tablet</td>
    
  </tr>
	 
  <tr>
    <td>Therapeutic Class:</td>
	<td>Anti-asthmatic</td>
    
    </tr>

   
  </tr>
	 
  <tr>
    <td>Sub Therapeutic class: </td>
	<td>Leukotriene Receptor Antagonist</td>
    
    </tr>
		
  
  <tr>
    <td>Commercial Pack:</td>
	<td>30’s </td>
    
  </tr>
	 
   <tr>
    <td>Price (TP):</td>
    <td>l0mg= 15 Tk./Tablet,<br>
	5mg Chew. & FT= 8Tk./Tablet, <br>
	4mg Chew.=6Tk./Tablet,<br>
	4 mg FT= 7 Tk./Tablet <br>
        </td>
	
   </tr>	
	 
   <tr>
 
    <td>Flavour </td>
    <td>4 mg (Vanilla) & 5 mg (Orange) Chewable,<br>
    4 mg (Banana) & 5 mg (Vanilla) Flash Tablet.</td>
	 
  </tr>
  
  <tr>
 
    <td>Indication </td>
    <td> 
For the treatment of Tinea Pedis, Tinea
Cruris & Tinea Corporis
</td>
  </tr>
  <tr>
<td>Pregnancy: 
</td>
<td>
US FDA approved pregnancy Category-B.<br><br>
The drug has been shown to
cross the placenta of pregnant rats and rabbits, but there have been no reports of
its use in pregnant women. 
</td>
</tr>
<tr>
<td>Lactation: 
</td>
<td>
Montelukast is also known to be excreted into
breast-milk, but only limited information is available on the significance of this
finding. Caution should be used prior to initiating montelukast therapy in nursing
mothers.

</td>
</tr>

  
  <tr>
 
    <td>Children: </td>
    <td>
From 6 month- 15 years.</td>
	 
  </tr>
  
   <tr>
 
    <td>Brand Name Justification: </td>
    <td> Airway + Montelukast.  </td>
	 
  </tr>
  
 <tr>
<td>Dosage & Administration: 
</td>
<td>
Adolescents & Adult (13 years & older)<br>
&#x2022; Tinea Corporis & Tinea Cruris: Once daily for 1 week
<br>
&#x2022; Tinea Pedis: Once daily for 2 weeks
</td>
</tr>
<tr>
<td>Key Selling Points: 
</td>
<td>
&#x2022; (1) Montelukast is the #1 prescribing anti-asthma drug worldwide.<br>
&#x2022; (2) Excellent for Long term use in chronic asthma & allergic rhinitis.<br>
&#x2022; (3) Ensures high success rate & better compliance In Children(Has no impact on children’s growth)<br>
&#x2022; (4) Suitable in pregnancy (Category-B)
</td>
</tr>
<tr>
<td>Target Doctor: 
</td>
<td>
&#x2022; Chest Specialists<br>
&#x2022; Medicine Specialists<br>
&#x2022; General Practioners<br>
&#x2022; ENT Specialists<br>
&#x2022; Child Specialists<br>
&#x2022; Diabetologists<br>
&#x2022; Cardiologists

</td>
</tr>
<tr>
<td>Side effects: 
</td>
<td>
&#x2022; 
Generally, Montelukast is well-tolerated. Side effects include dizziness, headache, diarrhea, restlessness, abdominal pain, cough, fever, asthenia, rash and upper respiratory tract infection.
</td>
</tr>
</table>
<br><br>


<table class="table2">
<thead>
<tr>
<th></th>
<th>Mode of action:</th>
</tr>
</thead>
<tbody>
<tr>
<td></td>
<td>Squalene</td>
</tr>
<tr>
<td></td>
<td>&#8681;</td>
</tr>
<tr>
<td>
</td>
<td>Squalene 2,3-epoxidase</td>
</tr>
<tr>
<td><b>Nafgal</b> interferes with sterol
biosynthesis by inhibiting the
enzyme squalene 2,3-epoxidase --></td>
<td>&#8681;</td>
</tr>
<tr>
<td></td>
<td>Lanosterol</td>
</tr>
<tr>
<td></td>
<td>&#8681;</td>
</tr>
<tr>
<td></td>
<td>Ergosterol</td>
</tr>
<tr>
<td></td>
<td>&#8681;</td>
</tr>
<tr>
<td></td>
<td>Synthesis of fungal cell</td>
</tr>
</tbody>
</table>
</div>   
<footer>
    <p>© 2024 Md. Nurullah. All rights reserved.</p>
</footer>
<center><div class="ovalEnd">The End-Nafgal</div></center><!--End Line---->
</body>
</html>